ETRGF - Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue Positive EBITDA And 'Substantial Growth' | Benzinga
Canadian cannabis producer and distributor Entourage Health Corp. (TSXV:ENTG) (OTCQX:ETRGF) (FSE:4WE) announced its first quarter financial results on Tuesday for the three months ended March 31, 2024.
The Toronto-based company reported a total revenue of CA$16.4 million ($12 million) (net revenue of CA$12.7 million, before excise duties and discounts), representing a 9% year-over-year increase.
"Entourage’s first quarter results are a testament to our robust financial health and strategic approach to business operations, positioning us for success throughout 2024," George Scorsis, the company's chair and CEO said. "With defined infrastructure and supply agreements in place, we are well-positioned to continue delivering the accelerated growth we have already seen develop in Q1."
Q1 2024 Financial Highlights
- Gross profit before changes in fair value amounted to CA$5.8 million, ...